SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-052431
Filing Date
2018-10-04
Accepted
2018-10-04 07:05:25
Documents
4
Period of Report
2018-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv504171_8k.htm 8-K 19181
2 EXHIBIT 99.1 tv504171_ex99-1.htm EX-99.1 17587
3 GRAPHIC image_002.jpg GRAPHIC 3427
4 GRAPHIC image_001.jpg GRAPHIC 5911
  Complete submission text file 0001144204-18-052431.txt   51193
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 181106901
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1